Crossref
OUTCOMES FOLLOWING NEOADJUVANT CHEMORADIATION VERSUS CHEMOTHERAPY ALONE FOR RESECTED DISTAL PANCREATIC ADENOCARCINOMA
HPB · 2026 · 28 · S30-S31
DOI: 10.1016/j.hpb.2026.04.049 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2026. Verfasst von D Patel und 2 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Patel, D., Hosseinpour, H., & Patel, D. (2026). OUTCOMES FOLLOWING NEOADJUVANT CHEMORADIATION VERSUS CHEMOTHERAPY ALONE FOR RESECTED DISTAL PANCREATIC ADENOCARCINOMA. HPB, 28, S30-S31. https://doi.org/10.1016/j.hpb.2026.04.049
Vancouver
Patel D, Hosseinpour H, Patel D. OUTCOMES FOLLOWING NEOADJUVANT CHEMORADIATION VERSUS CHEMOTHERAPY ALONE FOR RESECTED DISTAL PANCREATIC ADENOCARCINOMA. HPB. 2026;28:S30-S31. doi:10.1016/j.hpb.2026.04.049
BibTeX
@article{Patel2026,
author = {Patel, D and Hosseinpour, H and Patel, D.},
title = {OUTCOMES FOLLOWING NEOADJUVANT CHEMORADIATION VERSUS CHEMOTHERAPY ALONE FOR RESECTED DISTAL PANCREATIC ADENOCARCINOMA},
journal = {HPB},
year = {2026},
volume = {28},
pages = {S30--S31},
doi = {10.1016/j.hpb.2026.04.049}
}
EUVIMED